Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

3.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
3.5K
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

32
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
32
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

25
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
25
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

32
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
32
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

32
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
32
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

589
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
589

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of care reorganisation during COVID-19 waves on non-COVID-19 inpatients in a Swiss hospital: a retrospective cohort study.

Swiss medical weekly·2026
Same author

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Blood·2026
Same author

Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.

Bone marrow transplantation·2026
Same author

Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Bone marrow transplantation·2026
Same author

Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenza.

Antimicrobial agents and chemotherapy·2026
Same author

Plasma heme pool compartmentalization is linked to pathophysiology in Sickle Cell Disease.

PloS one·2026

Related Experiment Video

Updated: Feb 20, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

6.9K

[Reactive hemophagocytic syndrome].

Fiona Novotny1, Federico Simonetta2, Kaveh Samii2

  • 1Service de médecine interne générale, HUG, 1205 Genève.

Revue Medicale Suisse
|October 25, 2017
PubMed
Summary

Reactive hemophagocytic syndrome, a cytokine storm from immune overstimulation, is life-threatening. Early diagnosis using HScore and prompt treatment are critical for patient survival.

More Related Videos

Flow Cytometric Measurement Of ROS Production In Macrophages In Response To FcγR Cross-linking
13:20

Flow Cytometric Measurement Of ROS Production In Macrophages In Response To FcγR Cross-linking

Published on: March 7, 2019

16.6K
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

25.6K

Related Experiment Videos

Last Updated: Feb 20, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

6.9K
Flow Cytometric Measurement Of ROS Production In Macrophages In Response To FcγR Cross-linking
13:20

Flow Cytometric Measurement Of ROS Production In Macrophages In Response To FcγR Cross-linking

Published on: March 7, 2019

16.6K
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

25.6K

Area of Science:

  • Immunology
  • Hematology
  • Critical Care Medicine

Background:

  • Reactive hemophagocytic syndrome (RHS) results from immune system overstimulation, leading to a cytokine storm.
  • This condition is characterized by febrile cytopenia, hepatosplenomegaly, and multi-organ failure, posing a significant threat to life.
  • Diagnosis can be challenging, necessitating a comprehensive evaluation.

Purpose of the Study:

  • To highlight the diagnostic challenges of reactive hemophagocytic syndrome.
  • To emphasize the utility of the HScore in diagnosing RHS.
  • To stress the importance of identifying and treating the underlying cause of RHS.

Main Methods:

  • Utilizing the HScore, which assesses hyperferritinemia, hypertriglyceridemia, and hypofibrinogenemia.
  • Evaluating bone marrow for hemophagocytosis, though not definitive for diagnosis.
  • Investigating potential underlying causes such as infections, malignancies, or autoimmune disorders.

Main Results:

  • The HScore aids in diagnosing RHS by considering key laboratory findings.
  • Bone marrow hemophagocytosis is a supportive, but not essential, diagnostic criterion.
  • Identifying the root cause is crucial for effective management.

Conclusions:

  • Reactive hemophagocytic syndrome requires prompt recognition and management as a medical emergency.
  • Multidisciplinary collaboration, particularly with hematologists, is vital for optimal patient care.
  • Aggressive investigation and treatment of underlying etiologies are paramount for improving outcomes in RHS.